Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for PTSD
NCT00749203Phase 2Completed
- Start
- Jan 2009
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic stress disorder (PTSD). Started Jan 2009; status: completed.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00749203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00749203.